By transplanting myeloablated PyMT with Slit2- or PBS-treated allografts, we observed that Slit2 brought about changes directly in BMDM of tumor-bearing mice, which in turn enhanced their antitumor macrophage population and reduced tumor progression. Here, SLIT2 is linked to neoplasm.